Physician

Abel Antonio Casso Dominguez, M.D.

According to 2025 Medicare claims, Abel Dominguez, M.D. (NPI: 1629333513) practices interventional cardiology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from New York, NY. This provider's primary affiliated billing organization is ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (NPI: 1487912416; TIN: 611661781) and primary practice location at 10025-1716. Dominguez is affiliated with the CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under the REACH model.

Dominguez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 233 traditional Medicare patients, billed 635 HCPCS/CPT codes, and received $75,782 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 4,194 prescription claims across 479 beneficiaries totaling $800,102 in drug costs, led by Entresto (Sacubitril/Valsartan). 2023 DME data shows 12 claims. Open Payments data shows 17 records totaling $1,205. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $2,066 to $75,782. Similarly, Part D prescription costs have risen steadily, from $574 to $800,102. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	13	19	$2,066
2021	318	522	$28,097
2022	457	989	$92,969
2023	249	801	$111,175
2024	233	635	$75,782

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	27	$574
2018	14	111	$2,859
2019	14	59	$1,630
2020	N/R	30	$3,932
2021	22	34	$4,239
2022	183	832	$66,455
2023	369	2,840	$446,150
2024	479	4,194	$800,102

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	12	$858
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	34	37	$137
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	64	66	$114
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	112	251	$102
99239	Hospital discharge day management, more than 30 minutes	28	29	$99
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	68	125	$80

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Entresto	Sacubitril/Valsartan	155	10,170	$216,341
Jardiance	Empagliflozin	118	7,650	$143,288
Eliquis	Apixaban	134	7,425	$137,235
Camzyos	Mavacamten	11	330	$95,410
Xarelto	Rivaroxaban	56	2,760	$46,521

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$1,205	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abel Antonio Casso Dominguez, M.D.?

Tedicare shows public-source Medicare data for Abel Antonio Casso Dominguez, M.D. (NPI 1629333513), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abel Antonio Casso Dominguez, M.D. have ACO affiliation data?

Abel Antonio Casso Dominguez, M.D. is shown with ACO affiliation data for CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Abel Antonio Casso Dominguez, M.D.?

Abel Antonio Casso Dominguez, M.D. is linked to ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (billing NPI 1487912416) in the available physician profile data.

Does Abel Antonio Casso Dominguez, M.D. have Open Payments data?

Abel Antonio Casso Dominguez, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.